Plain-English translation of ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing , a new immunotherapy drug, combined with chemotherapy (a strong cancer-fighting medicine) and high-dose vitamin D3 in patients with advanced pancreatic cancer that has spread to other parts of the body. The goal is to see if this three-part treatment approach can shrink tumors and help patients live longer. This medication works by helping your immune system fight cancer cells.
Pancreatic cancer is a very serious disease, especially when it has spread. Standard chemotherapy alone doesn't work well enough for many patients. Researchers believe that adding this immunotherapy medication might help the chemotherapy work better by boosting your body's natural ability to fight cancer.
You likely qualify if…
You likely don't qualify if…
You would receive treatment at a hospital's cancer center in two phases: the first 4 cycles (about 6 months) of intensive chemotherapy combined with the new medication given through an IV every 3 weeks, followed by a maintenance phase with a gentler chemotherapy regimen and the medication given every 6 weeks, continuing until your cancer progresses. Throughout the trial, you'll have regular blood tests, scans to measure your tumor, and check-ins with your care team to monitor how well the treatment is working and manage any side effects. You'll also take vitamin D3 pills daily throughout your treatment.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
France